Anteo Diagnostics Ltd has released a press release.
Rights Issue Prospectus
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AnteoTech
- AnteoTech Granted Key US Battery Patent
- Response to ASXs Price Query
- Battery Program Update
- IMRA Contract Additional Information
- Response to ASX Aware Query
Later from AnteoTech
- Rights Commence Trading
- Heads of Agreement signed with Merck
- Rights Issue Raises $2.15 million
- R & D Refund Received
- AnteoTech and Axxin Build Successful Sepsis Multiplex Test
Follow AnteoTech into a list and get an email when it puts out news.
Follow AnteoTech